NCT05091151View on ClinicalTrials.gov

Intranasal Dexmedetomidine Sedation at Dose of 2 mcg/kg Versus 4 mcg/kg in Children Undergoing MRI

NACompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

April 30, 2019

Study Completion Date

June 30, 2019

Conditions
AnesthesiaDeep SedationMagnetic Resonance ImagingPediatric ALL
Interventions
DRUG

Intranasal dexmedetomidine at dose of 2 mcg/kg and 4 mcg/kg

Intranasal dexmedetomidine were given 45 minutes before the MRI procedure through both nostrils using a 1 mL syringe.

Trial Locations (1)

10430

Cipto Mangunkusumo General Hospital, Jakarta Pusat

All Listed Sponsors
lead

Indonesia University

OTHER

NCT05091151 - Intranasal Dexmedetomidine Sedation at Dose of 2 mcg/kg Versus 4 mcg/kg in Children Undergoing MRI | Biotech Hunter | Biotech Hunter